Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated Axtria Ignite 2025 conference, set to take place 4th-5th June at the
The FDA has completed a pilot of a new GenAI technology for speeding up drug reviews– And it wants to move from pilot to implementation in two months
An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?
Digital health firm Hinge has published a new prospectus for its IPO, shrugging off the weakness in US stock markets caused by Trump's tariffs.
Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients.
Editor's Picks
